Ex Parte Perego et al - Page 12




               Appeal No. 2006-0545                                                                        Page 12                   
               Application No. 10/019,273                                                                                            



               using tetramethylammonium hydroxide in the place of tetraalkylammonium hydroxide in                                   
               the process of forming ZSM-12.  However, the Examiner determined that the use of                                      
               tetramethylammonium hydroxide would have been obvious.  (Answer, p. 7).  Appellants                                   
               have failed to specifically address the Examiner’s position in responsive briefing.                                   
                       Appellants assert that claim 13 is separately patentable because Rosinski directs                             
               persons skilled in the art to a particularly preferred molar ratio of 90-100 and away from                            
               the molar ratio of the claim.  Claim 13 describes the molar ratio of silica/alumina ranging                           
               from 150 to 200.  The Examiner has failed to identify the portion of the Leyshon and                                  
               Rosinski references that discloses or suggests the claimed molar ratio. The Examiner                                  
               has not adequately explained how the Rosinski disclosure of a ZSM-12 that having a                                    
               silica/alumina molar ratio range of 20-100 suggests the claimed molar ratio of                                        
               silica/alumina ranging from 150 to 200.  The Examiner has also failed to identify why the                             
               claimed molar ratios would have been obvious.  Thus, the Examiner has failed to                                       
               establish a prima facie case.  The rejection of claim 13 is reversed.                                                 
                                                         CONCLUSION                                                                  
                       The rejections under ' 112, first and second paragraphs, are reversed.  The                                   
               ' 103 rejection of claim 13 over Leyshon and Rosinski is reversed.  The ' 103 rejection                               
               of claims 1-12, 14, and 17-20 over Leyshon and Rosinski is affirmed.                                                  










Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007